54 related articles for article (PubMed ID: 7064851)
41. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
Mehta J; Feldman RL; Marx JD; Kelly GA
Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
[TBL] [Abstract][Full Text] [Related]
42. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
Condorelli M; Brevetti G; Chiariello M; Miceli D; Lavecchia G; Paudice G; Verrienti S
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):101S-110S. PubMed ID: 7093092
[TBL] [Abstract][Full Text] [Related]
43. Circulatory responses to thiopentone and tracheal intubation in patients with coronary artery disease. Effects of pretreatment with labetalol.
Fischler M; Dubois C; Brodaty D; Schlumberger S; Melchior JC; Guilmet D; Vourc'h G
Br J Anaesth; 1985 May; 57(5):493-6. PubMed ID: 3888239
[TBL] [Abstract][Full Text] [Related]
44. Systemic and coronary hemodynamic effects of combined oral alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress tests.
Feldman RL; Prida XE; Hill JA
Clin Cardiol; 1988 Jun; 11(6):383-8. PubMed ID: 3396239
[TBL] [Abstract][Full Text] [Related]
45. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
Sladen RN; Klamerus KJ; Swafford MW; Prough DS; Mann HJ; Leslie JB; Goldberg JS; Levitsky S; Molina JE; Mills SA
J Cardiothorac Anesth; 1990 Apr; 4(2):210-21. PubMed ID: 2131869
[TBL] [Abstract][Full Text] [Related]
46. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
[TBL] [Abstract][Full Text] [Related]
47. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
48. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
49. Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.
Frishman WH
Cardiovasc Drugs Ther; 1988 Sep; 2(3):343-53. PubMed ID: 2908732
[TBL] [Abstract][Full Text] [Related]
50. Treatment of hypertension in the elderly with labetalol.
Sirgo MA; Boyd BK; Applegate WB
Pharmacotherapy; 1989; 9(5):295-302. PubMed ID: 2682551
[TBL] [Abstract][Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
